HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Biwei Yang Selected Research

Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)

1/2020TIPE1 impairs stemness maintenance in colorectal cancer through directly targeting β-catenin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Biwei Yang Research Topics

Disease

16Neoplasms (Cancer)
06/2023 - 05/2015
14Hepatocellular Carcinoma (Hepatoma)
01/2023 - 08/2011
5Liver Neoplasms (Liver Cancer)
09/2021 - 08/2011
5Neoplasm Metastasis (Metastasis)
09/2021 - 01/2015
1Adenocarcinoma of Lung
05/2021
1Fibrosis (Cirrhosis)
01/2021
1Glioblastoma (Glioblastoma Multiforme)
12/2020
1Colorectal Neoplasms (Colorectal Cancer)
01/2020
1Colonic Neoplasms (Colon Cancer)
01/2020
1Carcinogenesis
01/2019
1Cholangiocarcinoma
01/2018
1Inflammation (Inflammations)
01/2017
1Breast Neoplasms (Breast Cancer)
05/2015

Drug/Important Bio-Agent (IBA)

3Proteins (Proteins, Gene)FDA Link
04/2021 - 12/2019
2CateninsIBA
01/2020 - 01/2019
2Phospholipases (Phospholipase)IBA
12/2019 - 05/2019
1RNA (Ribonucleic Acid)IBA
06/2023
1EnzymesIBA
06/2023
1Programmed Cell Death 1 ReceptorIBA
01/2023
1Tryptophan (L-Tryptophan)FDA Link
01/2023
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
01/2022
1Sorafenib (BAY 43-9006)FDA Link
09/2021
1NexusIBA
09/2021
13,7,11,15- tetramethyl- 2,4,6,10,14- hexadecapentaenoic acidIBA
09/2021
1RetinoidsIBA
09/2021
1ErbB Receptors (EGF Receptor)IBA
05/2021
1Tyrosine Kinase InhibitorsIBA
05/2021
1SubtilisinIBA
04/2021
1Competitive Endogenous RNAIBA
01/2021
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2021
1Alanine Transaminase (SGPT)IBA
01/2021
1Indicators and Reagents (Reagents)IBA
01/2021
1Long Noncoding RNAIBA
01/2021
1Protein Isoforms (Isoforms)IBA
12/2020
1Casein Kinase I (Casein Kinase 1)IBA
12/2020
1IC 261IBA
12/2020
1Matrix Metalloproteinase 17IBA
08/2020
1Interleukin-10 (Interleukin 10)IBA
02/2020
1CytokinesIBA
02/2020
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020
1Peptide Hydrolases (Proteases)FDA Link
01/2020
1LuciferasesIBA
01/2020
1Peptides (Polypeptides)IBA
12/2019
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
12/2019
1Conditioned Culture MediaIBA
10/2019
1obeticholic acidIBA
01/2018
1Messenger RNA (mRNA)IBA
01/2018
1Biomarkers (Surrogate Marker)IBA
01/2018
1Interleukin-6 (Interleukin 6)IBA
01/2018
1CholesterolIBA
01/2017
1Insulin-Like Growth Factor I (IGF-1)IBA
01/2015
1Caveolin 1IBA
01/2015
1Recombinant ProteinsIBA
07/2014
1Small Interfering RNA (siRNA)IBA
07/2014
1Lamivudine (Epivir)FDA Link
06/2014

Therapy/Procedure

6Therapeutics
01/2023 - 08/2011
1Immunotherapy
06/2023
1Aftercare (After-Treatment)
05/2021
1Intraperitoneal Injections
12/2020
1Ligation
12/2019
1Metastasectomy
05/2015
1Radiofrequency Ablation
08/2011